Vascular Imaging With Ferumoxytol as a Contrast Agent

Ferumoxytol is increasingly reported as an alternative to gadolinium-based contrast agents for MR angiography (MRA), particularly for patients with renal failure. This article summarizes more than 3 years of clinical experience with ferumoxytol-enhanced MRA for a range of indications and anatomic re...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of roentgenology (1976) Vol. 205; no. 3; pp. W366 - W373
Main Authors Hope, Michael D, Hope, Thomas A, Zhu, Chengcheng, Faraji, Farshid, Haraldsson, Henrik, Ordovas, Karen G, Saloner, David
Format Journal Article
LanguageEnglish
Published United States 01.09.2015
Subjects
Aged
Aged, 80 and over
Contrast Media
Female
Ferrosoferric Oxide
Humans
Image Enhancement
Imaging, Three-Dimensional
Magnetic Resonance Angiography
Male
Middle Aged
Retrospective Studies
Vascular Diseases - diagnosis
navigated MRA
ultrasmall superparamagnetic iron oxide (USPIO)
inflammation
contrast agents
ferumoxytol
4D flow
MR angiography (MRA)
Online AccessGet full text

Cover

More Information
Summary:Ferumoxytol is increasingly reported as an alternative to gadolinium-based contrast agents for MR angiography (MRA), particularly for patients with renal failure. This article summarizes more than 3 years of clinical experience with ferumoxytol-enhanced MRA for a range of indications and anatomic regions. Ferumoxytol-enhanced MRA has many advantages including that it is safe for patients with renal failure and provides a lengthy plateau of vascular signal as a blood pool agent that allows longer navigated MRA sequences.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0361-803X
1546-3141
DOI:10.2214/AJR.15.14534